The Association Between TNF-receptors (TNFR1 and TNFR2) and Mortality As Well As Kidney Function Decline in Patients with Chronic Kidney Disease

Overview

Journal Ups J Med Sci

Specialty General Medicine

Date 2024 Dec 19

PMID 39697981

Authors

Per Wandell

Tobias Feldreich

Anders Larsson

Philip A Kalra

Johan Arnlov

Toralph Ruge

Axel C Carlsson

Affiliations

Soon will be listed here.

Abstract

Background: Higher circulating levels of tumor necrosis factor (TNF) alpha receptors 1 (TNFR1) and 2 (TNFR2) are associated with increased long-term mortality and impaired kidney function.

Aim: To study associations between levels of TNFR1 and TNFR2 and all-cause mortality as well as estimated glomerular filtration rate (eGFR) decline.

Population And Methods: Patients with chronic kidney disease (CKD) stages 3-5 in the Salford Kidney Study were included. Associations between one standard deviation increase in TNFR1 and TNFR2 and mortality were estimated by Cox regression models with hazard ratios (HRs) and 95% confidence intervals adjusted for age, sex, eGFR based on creatinine and cystatin C, urine-protein, C-reactive protin, cardiovascular comorbidity, smoking habits, and diabetes. Differences in eGFR decline in relation to TNFR1 and TNFR2 were estimated by both linear and logistic regression models, with regression coefficients and odds ratios (ORs).

Results: Univariate models showed significant associations between TNFR1 and TNFR2 and all-cause mortality based on 7424 person-years at risk, but in the fully adjusted models with continuous variables significant only for TNFR2 HR 1.17 (1.03-1.34), but with a borderline value for TNFR1 HR 1.15 (1.00-1.31). For rapid decliners, that is, eGFR decline in highest TNFR-receptor quartile versus quartiles 1-3, the decline was 1.60% per month (interval 0.78-10.99). For eGFR decline in continuous models, the fully adjusted ORs were for TNFR1 1.29 (0.92-1.81) and for TNFR2 1.33 (0.90-1.98).

Conclusions: TNFR2 was associated with mortality, but TNFR1 was not, although showing a borderline value. Neither TNFR1 nor TNFR2 predicted decline in kidney function. TNFR1 and TNFR2 portray interesting aspects in patients with CKD, but the clinical utility seems limited.

References

Evans M, Grams M, Sang Y, Astor B, Blankestijn P, Brunskill N . Risk Factors for Prognosis in Patients With Severely Decreased GFR. Kidney Int Rep. 2018; 3(3):625-637. PMC: 5976849. DOI: 10.1016/j.ekir.2018.01.002. View

Carlsson A, Nordquist L, Larsson T, Carrero J, Larsson A, Lind L . Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals. Cardiorenal Med. 2015; 5(4):278-88. PMC: 4662300. DOI: 10.1159/000435863. View

Yang S, Wang J, Brand D, Zheng S . Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications. Front Immunol. 2018; 9:784. PMC: 5916970. DOI: 10.3389/fimmu.2018.00784. View

Tollitt J, Odudu A, Montaldi D, Kalra P . Cognitive impairment in patients with moderate to severe chronic kidney disease: the Salford kidney cohort study. Clin Kidney J. 2021; 14(6):1639-1648. PMC: 8162857. DOI: 10.1093/ckj/sfaa178. View

Gomez-Banoy N, Cuevas V, Higuita A, Aranzalez L, Mockus I . Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes. J Diabetes Complications. 2016; 30(5):852-7. DOI: 10.1016/j.jdiacomp.2016.03.015. View

Saulnier P, Gand E, Ragot S, Ducrocq G, Halimi J, Hulin-Delmotte C . Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort. Diabetes Care. 2014; 37(5):1425-31. DOI: 10.2337/dc13-2580. View

Cabal-Hierro L, Lazo P . Signal transduction by tumor necrosis factor receptors. Cell Signal. 2012; 24(6):1297-305. DOI: 10.1016/j.cellsig.2012.02.006. View

Carlsson A, Juhlin C, Larsson T, Larsson A, Ingelsson E, Sundstrom J . Soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with increased total mortality due to cancer and cardiovascular causes - findings from two community based cohorts of elderly. Atherosclerosis. 2014; 237(1):236-42. DOI: 10.1016/j.atherosclerosis.2014.09.005. View

Marshall S, Flyvbjerg A . Prevention and early detection of vascular complications of diabetes. BMJ. 2006; 333(7566):475-80. PMC: 1557968. DOI: 10.1136/bmj.38922.650521.80. View

10.

Carlsson A, Ingelsson E, Sundstrom J, Carrero J, Gustafsson S, Feldreich T . Use of Proteomics To Investigate Kidney Function Decline over 5 Years. Clin J Am Soc Nephrol. 2017; 12(8):1226-1235. PMC: 5544512. DOI: 10.2215/CJN.08780816. View

11.

Fernandez-Real J, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J . Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes. 1998; 47(11):1757-62. DOI: 10.2337/diabetes.47.11.1757. View

12.

Speeckaert M, Speeckaert R, Laute M, Vanholder R, Delanghe J . Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases. Am J Nephrol. 2012; 36(3):261-70. DOI: 10.1159/000342333. View

13.

Enoksen I, Rinde N, Svistounov D, Norvik J, Solbu M, Eriksen B . Validation of eGFR for Detecting Associations Between Serum Protein Biomarkers and Subsequent GFR Decline. J Am Soc Nephrol. 2023; 34(8):1409-1420. PMC: 10400103. DOI: 10.1681/ASN.0000000000000147. View

14.

Coresh J, Turin T, Matsushita K, Sang Y, Ballew S, Appel L . Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014; 311(24):2518-2531. PMC: 4172342. DOI: 10.1001/jama.2014.6634. View

15.

Idriss H, Naismith J . TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech. 2000; 50(3):184-95. DOI: 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H. View

16.

Wandell P, Carlsson A, Larsson A, Melander O, Wessman T, Arnlov J . TNFR1 is associated with short-term mortality in patients with diabetes and acute dyspnea seeking care at the emergency department. Acta Diabetol. 2020; 57(10):1145-1150. PMC: 7496043. DOI: 10.1007/s00592-020-01527-3. View

17.

Premaratne E, Verma S, Ekinci E, Theverkalam G, Jerums G, MacIsaac R . The impact of hyperfiltration on the diabetic kidney. Diabetes Metab. 2014; 41(1):5-17. DOI: 10.1016/j.diabet.2014.10.003. View

18.

Morange P, Tregouet D, Godefroy T, Saut N, Bickel C, Rupprecht H . Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study. J Mol Med (Berl). 2008; 86(10):1153-61. DOI: 10.1007/s00109-008-0375-6. View

19.

Libby P . Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32(9):2045-51. PMC: 3422754. DOI: 10.1161/ATVBAHA.108.179705. View

20.

Carlsson A, Ostgren C, Nystrom F, Lanne T, Jennersjo P, Larsson A . Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes. Cardiovasc Diabetol. 2016; 15:40. PMC: 4770690. DOI: 10.1186/s12933-016-0359-8. View